Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07213232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dual-Task Balance and Gait Training Combined With Cognitive Training in Parkinson's Patients

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion date changed from estimate of Oct 3, 2026 to Sep 3, 2026
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Publications: details revised at 10 of 10 entries
  2. Minor Primary completion pushed from Jun 3, 2026 to Oct 3, 2026
    • Study completion pushed from Jun 3, 2026 to Dec 3, 2026
    v4
  3. Notable Primary completion date: Dec 3, 2025 to Jun 3, 2026
    • Study completion date: Mar 3, 2026 to Jun 3, 2026
    v3
  4. Minor Re-verified, no change to tracked fieldsv2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to examine the effects of a structured, cognitive dimension-specific cognitive training combined with dual-task balance and gait training on balance, gait, and cognition in individuals with Parkinson's disease.
Trial Details
NCT Number NCT07213232
Lead Sponsor Gazi University
Collaborators: T.C. Sağlık Bakanlığı Ankara Bilkent Şehir Hastanesi
Conditions
(from sponsor)
Cognition, Parkinson's Disease, Gait Disorders, Neurologic, Balance Disorders
Related terms Gait Disorders, Neurologic, Parkinson Disease
Enrollment 14 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov